Chinese biotech startup Ionova secures $100m to advance oncology drug pipeline

Chinese biotech startup Ionova secures $100m to advance oncology drug pipeline

Photo by Louis Reed on Unsplash

23 August, 2021

biotech Greater Bay Area Homeland Development Fund Ionova Life Science Shenzhen Capital Group Tsing Song Capital

Printed by Unregistered user on Tue, 23 Dec 2025 06:34:21 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

HK-listed Genscript Biotech unit Probio to raise $150m from Hillhouse Capital

CPE, China Structural Reform Fund lead $100m round in biotech firm TransThera

Read more from Greater China

ByteDance plans to spend $23b towards AI infrastructure in 2026

China Deal Review: Startup funding slows down in Nov as mega deals dwindle